LANXESS completes acquisition of Brazilian biocide manufacturer IPEL

Cologne

Specialty chemicals company LANXESS today, February 3, 2020, completed the acquisition of Itibanyl Produtos Especiais Ltda. (IPEL). The competent anti-trust authorities approved the transaction beginning of January.

IPEL with headquarters in Jarinu, São Paulo, is one of Brazil’s leading biocide manufacturers and generated sales in the lower double-digit million euro range in 2018. With the acquisition, LANXESS is strengthening its position as one of the world’s leading manufacturers of antimicrobial active ingredients and formulations. In addition to around 100 employees and the production facility, LANXESS has taken over the Brazilian company’s laboratory facilities.

IPEL generates the majority of its sales with biocides and specialty chemicals for the paint and coating industry. The product portfolio also includes preservatives and fungicides for process control in water treatment as well as active ingredients for disinfection and cleaning agents.

MORE ABOUT THIS TOPIC

PRESS RELEASE

LANXESS expects earnings improvement for fiscal year 2024

March 14, 2024
INVESTOR NEWS

LANXESS again with top positions in sustainability ratings

December 08, 2023
INVESTOR NEWS

Lithium project: LANXESS plans to supply Standard Lithium with lithium-rich brine

December 01, 2023
INVESTOR NEWS

Persistently weak demand impacts third quarter

November 08, 2023
AD HOC

LANXESS adjusts expectations FY 2023; Board of Management proposes dividend reduction

November 06, 2023